The Leadership Team at CellCarta provides strategic direction and oversight across the company's diverse divisions, including immune monitoring, proteomics, and biomarker research. Comprised of experienced executives in finance, science, commercial operations, and regulatory affairs, this team ensures the alignment of CellCarta's goals with industry standards, drives innovation, and fosters growth in the specialty CRO laboratory space. Their collaborative efforts are crucial for advancing scientific advancements and enhancing the company's market presence.
Anthony Mattacchione
Global Chief Financial Officer
Christopher Ung
Chief Scientific Business Offi...
Dirk Hendriks
SVP & CFO, HistoCarta & GeneCa...
Hayden Routledge
Global Chief Commercial Office...
Kristien Verhoeven
COO, HistoCarta & GeneCarta
Lorella Di Donato
COO, Immunology & Proteomics D...
Mark Kockx
Chief Scientific Officer & Med...
Martin Leblanc
Co-Founder & Vice-Chairman
Todd Chermak
Chief Regulatory & Government ...
View all